Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
400,000
+150,000
+60% +$424K 0.76% 53
2026
Q1
$605K Buy
+250,000
New +$682K 0.51% 60

Other funds holding GNLX

CM Management's GNLX Position: Q2 2026 in Review

CM Management increased its Genelux (GNLX) stake by 60% in Q2 2026, buying an estimated $424K and bringing the position to 400,000 shares worth $1.2M. The position accounts for 0.76% of the portfolio, ranked #53.

CM Management first reported a position in GNLX in Q1 2026 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • CM Management held 400,000 shares of Genelux worth $1.2M as of Q2 2026.
  • CM Management bought 150,000 Genelux shares in Q2 2026, an estimated $424K.
  • Genelux made up 0.76% of CM Management's portfolio in Q2 2026, its #53 holding.
  • CM Management first reported a position in Genelux in Q1 2026 and has held it in 2 quarters since.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.